ReviewCell communication and signaling : CCS2026
The roles of IKKα in normal physiology and cancer.
Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IkappaB kinase alpha (IKKα) is a multifunctional serine/threonine kinase and a core component of the IKK complex, best known for its central role in canonical and non-canonical nuclear factor kappaB (NF-κB) signalling. While early studies primarily focused on these roles in NF-κB signalling, emerging evidence highlights a much broader spectrum of functions, extending far beyond these classical roles. IKKα is now known to govern diverse biological processes, including cell cycle regulation, epidermal differentiation, tissue homeostasis and development through NF-κB-independent mechanisms, acting as a transcriptional and epigenetic regulator and signalling mediator. In cancer, IKKα has dual, context-specific activities, both as a tumour suppressor through inhibition of cell growth in some settings, while also working as a potent oncogene driving cell proliferation, metastasis and therapy resistance in other settings. This review synthesises the current knowledge of IKKα in both physiological and pathological contexts, highlighting its multifaceted roles in cancer development and discussing emerging therapies targeting IKKα for cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.